Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 79.00
-1.20 (-1.50%)
Jan 7, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 394.94 million as of January 7, 2026. Its market cap has increased by 4.97% in one year.
Market Cap
394.94M
Enterprise Value
371.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
79.00
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 394.94M, an increase of 243.32%. That is a compound annual growth rate of 34.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 394.94M | 3.35% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.70B |
| Synektik Spólka Akcyjna | 2.46B |
| Voxel | 1.28B |
| Celon Pharma | 1.10B |
| Selvita | 811.31M |
| Ryvu Therapeutics | 627.71M |
| Centrum Medyczne ENEL-MED | 509.05M |